loss-of-function mutation as a rare cause of parathyroid (PTH)-independent severe hypercalcaemia in pregnancy.
作者信息
Morton Adam
机构信息
Obstetric Medicine and Endocrinology, Mater Health, South Brisbane, Australia.
出版信息
Obstet Med. 2025 Aug 4:1753495X251349953. doi: 10.1177/1753495X251349953.
Abstract
摘要
相似文献
1
loss-of-function mutation as a rare cause of parathyroid (PTH)-independent severe hypercalcaemia in pregnancy.
Obstet Med. 2025 Aug 4:1753495X251349953. doi: 10.1177/1753495X251349953.
2
Intractable hypercalcaemia during pregnancy and the postpartum secondary to pathogenic variants in CYP24A1.
Endocrinol Diabetes Metab Case Rep. 2019 Nov 21;2019. doi: 10.1530/EDM-19-0114.
3
Persistent hypercalcaemia associated with two pathogenic variants in the gene and a parathyroid adenoma-a case report and review.
Front Endocrinol (Lausanne). 2024 Apr 11;15:1355916. doi: 10.3389/fendo.2024.1355916. eCollection 2024.
4
[CYP24A1 gene defect manifesting with gestational hypercalcemia].
Orv Hetil. 2022 Jul 31;163(31):1237-1242. doi: 10.1556/650.2022.32520.
5
In Vivo Contribution of Cyp24a1 Promoter Vitamin D Response Elements.
Endocrinology. 2024 Sep 26;165(11). doi: 10.1210/endocr/bqae134.
6
Eiken syndrome with parathyroid hormone resistance due to a novel parathyroid hormone receptor type 1 mutation: clinical features and functional analysis.
J Bone Miner Res. 2024 Oct 29;39(11):1596-1605. doi: 10.1093/jbmr/zjae148.
7
Rapid genomic changes by mineralotropic hormones and kinase SIK inhibition drive coordinated renal Cyp27b1 and Cyp24a1 expression via CREB modules.
J Biol Chem. 2022 Nov;298(11):102559. doi: 10.1016/j.jbc.2022.102559. Epub 2022 Sep 30.
8
Genomic Mechanisms Governing Mineral Homeostasis and the Regulation and Maintenance of Vitamin D Metabolism.
JBMR Plus. 2020 Dec 5;5(1):e10433. doi: 10.1002/jbm4.10433. eCollection 2021 Jan.
9
Clinical and laboratory features of calcium-sensing receptor disorders: a systematic review.
Ann Clin Biochem. 2004 Nov;41(Pt 6):441-58. doi: 10.1258/0004563042466802.
10
Hypervitaminosis D Secondary to a Loss-of-Function Mutation: An Unusual Cause of Hypercalcemia in Two Siblings.
JBMR Plus. 2023 Aug 8;7(9):e10788. doi: 10.1002/jbm4.10788. eCollection 2023 Sep.
本文引用的文献
1
A rare example of humoral-related hypercalcaemia in pregnancy secondary to a uterine fibroid: a case report.
Obstet Med. 2025 Apr 11:1753495X251326130. doi: 10.1177/1753495X251326130.
2
Case report: Non-PTH-dependent hypercalcemia in pregnancy: Consider CYP24A1 mutations.
Ann Endocrinol (Paris). 2023 Dec;84(6):758-760. doi: 10.1016/j.ando.2023.05.009. Epub 2023 Jun 13.
3
Hypercalcemia in Pregnancy Due to CYP24A1 Mutations: Case Report and Review of the Literature.
Nutrients. 2022 Jun 17;14(12):2518. doi: 10.3390/nu14122518.
4
Long-term Efficacy and Safety of Rifampin in the Treatment of a Patient Carrying a CYP24A1 Loss-of-Function Variant.
J Clin Endocrinol Metab. 2022 Jul 14;107(8):e3159-e3166. doi: 10.1210/clinem/dgac315.
5
Hypercalcemia due to CYP24A1 mutations: a systematic descriptive review.
Eur J Endocrinol. 2021 Dec 10;186(2):137-149. doi: 10.1530/EJE-21-0713.
Zotero 插件